Last reviewed · How we verify
NCT07396363
Psychoeducational Psychotherapy in Adolescent Bipolar Disorder
NA trial testing Psychoeducational psychotherapy (PEP) in Bipolar Disorder (BD) in 32 participants. Completed in 23 December 2022.
23 December 2022
Quick facts
| Lead sponsor | Dokuz Eylul University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 24 January 2017 |
| Primary completion | 23 December 2022 |
| Estimated completion | 23 December 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Psychoeducational psychotherapy (PEP)
Conditions studied
- Bipolar Disorder (BD) — all drugs for Bipolar Disorder (BD) →
Sponsor
Dokuz Eylul University
Who can join
Adults 12 to 18, any sex, with Bipolar Disorder (BD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluated the effects of psychoeducational psychotherapy (PEP) on neurocognitive functions, symptomatology, quality of life, and emotion regulation in euthymic adolescents with bipolar disorder (BD). Thirty-two adolescents with BD were randomized, with 16 receiving PEP. Assessments included the Wisconsin Card Sorting Test, Stroop Test, Pediatric Quality-of-Life Inventory, Difficulties in Emotion Regulation Scale (DERS), Affective Reactivity Index, Young Mania Rating Scale, and Children's Depression Rating Scale.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07396363
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bipolar Disorder (BD)
Currently open trials in the same condition.
- NCT07213492 — Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder · NA · recruiting
- NCT07589647 — Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic D · NA · recruiting
- NCT07306039 — Feasibility of eLi12 · NA · active not recruiting
- NCT07404085 — Epigenetic Enhancement of Cognitive Training in Aging Mood Disorder Populations · NA · recruiting
- NCT07306468 — Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life · recruiting
Other Dokuz Eylul University trials
Trials by the same sponsor.
- NCT07464626 — Virtual vs Physical Art Therapy for Anxiety, Psychological Well-being, and Sleep Quality in Colorectal Cancer Patients · NA · recruiting
- NCT07299058 — The Effect of a Guessing Game on Fear, Pain, and Emotional State During Blood Collection in Children Aged 6-12 · NA · not yet recruiting
- NCT07205965 — The Effect of Acceptance and Commitment Approach-Based Psychoeducation in Cancer Survivors · NA · active not recruiting
- NCT07141953 — Yoga in Women With Surgical Menopause After Gynecological Cancer · NA · not yet recruiting
- NCT07152665 — The Effect of Video-Based Educational Content for Parents and Children on Anxiety, Fear, and Pain During Blood Draw in C · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07396363 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dokuz Eylul University
- Last refreshed: 10 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07396363.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing